ArticleJournal of vision2023
The time course of chromatic adaptation in human early visual cortex revealed by SSVEPs.
Article in Journal of vision, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 10 citations in OpenAlex.
- The contribution of the koniocellular visual pathway to aversive learning in human visual cortex.Journal of neurophysiology · 2026Article
- Cone-Specific Filter-Based Neuromodulation: A Proposed Clinical Framework for Amblyopia, Strabismus, and ADHD.Clinics and practice · 2025Article
- Interocular suppression in chromoluminance patterns measured with SSVEP.Journal of vision · 2025Article
- Tuning of cortical color mechanisms revealed using steady-state visually evoked potentials.Imaging neuroscience (Cambridge, Mass.) · 2025Article
- Measurements of chromatic adaptation and luminous efficiency while wearing colored filters.Journal of vision · 2024Article
- Frequency-dependent dynamics of steady-state visual evoked potentials under sustained flicker stimulation.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Previous studies have identified at least two components of chromatic adaptation: a rapid component with a time scale between tens of milliseconds to a few seconds, and a slow component with a half-life of about 10 to 30 seconds. The basis of the rapid adaptation probably lies in receptor adaptation at the retina. The neural substrate for the slow adaptation remains unclear, although previous psychophysical results hint at the early visual cortex. A promising approach to investigate adaptation effects in the visual cortex is to analyze steady-state visual evoked potentials (SSVEPs) elicited by chromatic stimuli, which typically use long durations of stimulation. Here, we re-analyzed the data from two previous pattern-reversal SSVEP studies. In these experiments (N = 49 observers in total), SSVEPs were elicited by counter-phase flickering color- or luminance-defined grating stimuli for 150 seconds in each trial. By analyzing SSVEPs with short time windows, we found that chromatic SSVEP responses decreased with increasing stimulation duration and reached a lower asymptote within a minute of stimulation. The luminance SSVEPs did not show any systematic adaptation. The time course of chromatic SSVEPs can be well described by an exponential decay function with a half-life of about 20 seconds, which is very close to previous psychophysical reports. Despite the difference in stimuli between the current and previous studies, the coherent time course may indicate a more general adaptation mechanism in the early visual cortex. In addition, the current result also provides a guide for future color SSVEP studies in terms of either avoiding or exploiting this adaptation effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.